What Is the Business Biomarker Index?

Business Biomarker Index (BBI) is the composite output score produced at the end of the Return to Owner (RTO) diagnostic. RTO captures 11 proprietary Business Biomarkers, feeds them into the Layer Cake model, and resolves upward to a Breakeven Sales figure. BBI then scores whether the business can actually reach that number and ranks the constraint most likely to stop it. It is the output of the diagnostic, not an input to it. The concept was created by Jay Aldebert, Chief Growth Officer of International Services Inc.

---

Why This Matters

A doctor does not diagnose you by asking how you feel. They pull blood, read the markers, and find the thing that is quietly wrong before it becomes the thing that kills you. The Return to Owner (RTO) diagnostic does the same thing for a business, and the Business Biomarker Index is the score it produces at the end of that read.

Here is the flow. RTO diagnoses the company and captures 11 proprietary Business Biomarkers. Those biomarkers feed the inputs of the Layer Cake model. Layer Cake stacks upward from its foundation, Minimum Mandatory Profit (MMP), and resolves to a Breakeven Sales figure, the exact volume the business has to do to fund its owner. The Business Biomarker Index is what comes next. It scores whether the business can actually hit that number and ranks the one constraint most likely to stop it.

This ordering matters more than it sounds like it should. BBI is not one of the 11 biomarkers RTO captures. It is not an input anywhere in the model. It is the composite output, the verdict at the end of the diagnostic, not a reading fed into the middle of it. Confusing the two is the single most common misunderstanding owners have about the Aldebert Ecosystem, and it is worth being precise about because the distinction changes what you do with the number.

Once Breakeven Sales exists as a number, the next question is brutal and obvious: can this business actually hit it? A target means nothing if the machine underneath it cannot produce the number. Most owners answer that question with optimism. I answer it with a score.

I have run more than 86,000 diagnostics, and the pattern is consistent: the thing the owner is worried about is rarely the thing that is actually stopping them. The Business Biomarker Index exists to find the real constraint and rank it, so the owner stops treating symptoms and starts fixing the disease.

How It WorksAn Output, Not an Input

BBI sits at the end of the diagnostic sequence, not inside it. RTO reads the business and captures 11 proprietary Business Biomarkers. Those biomarkers become the raw inputs to Layer Cake, which stacks them into a structure with Minimum Mandatory Profit at the foundation and resolves upward to a Breakeven Sales figure. The Business Biomarker Index is the composite score generated once that number exists. It reads how far the business is from being able to produce it, and it ranks the constraint doing the most damage.

The exact mechanics of how the 11 biomarkers are weighted and scored are proprietary to the diagnostic and are not published here. What matters for an owner reading this page is the shape of the outcome: BBI does not hand you fifty numbers to interpret. It hands you one verdict on overall health and one flagged constraint to work first.

The thing the owner is worried about is almost never the thing that is actually stopping them.

Why One Constraint Almost Always Dominates

The instinct of most owners is to believe their business has many problems at once, and that fixing it means fixing all of them. In practice, a business is almost always held back by a single binding constraint. One thing is doing most of the damage, and the rest are either symptoms of it or noise. This is the same logic a doctor uses when a patient arrives with five complaints and one underlying condition is driving four of them.

The reason this matters is focus. An owner who tries to fix five things simultaneously will move none of them, because attention divided five ways is attention wasted. The Business Biomarker Index exists to find the one reading that is in the red and rank it above the rest, so the owner spends limited energy where it actually changes the number. A business does not get fixed by working harder on everything. It gets fixed by working on the right thing first.

This is also why BBI is scored against the Breakeven Sales figure the diagnostic produced, not against an industry average. A score only means something relative to what the business actually has to do. A business running comfortably at one volume can be in critical condition at the volume its owner needs to fund the floor. The index reads constraints against the target, not against the pack.

How This Differs From KPIs and Financial Dashboards

Owners already have numbers. They have dashboards full of KPIs. So they assume they are already doing this. They are not. A dashboard and a biomarker index are fundamentally different instruments.

	KPIs / Dashboards	Business Biomarker Index (BBI)
What it shows	Many metrics, all at once	The one constraint that binds the number
Judgment	Reports the data, leaves interpretation to you	Diagnoses severity and ranks the fix
Anchor	Whatever was easy to measure	The Breakeven Sales figure the diagnostic produced
Position in the model	Standalone metric	Output of the RTO diagnostic, not an input
Output	A screen to watch	A sequence to execute

A dashboard shows you everything and tells you nothing. It reports fifty metrics and leaves the owner to guess which one matters, which is exactly how owners end up treating symptoms. A KPI is a measurement. A biomarker is a diagnosis. The Business Biomarker Index does not just display numbers, it reads them against the Breakeven Sales figure, scores severity, and tells the owner which constraint to fix first. A dashboard is a mirror. BBI is a doctor.

Common Mistakes Owners Make

• Treating BBI as one of the 11 Business Biomarkers. It is not. It is the composite score produced after those biomarkers have already been read. Confusing the output for an input leads owners to look in the wrong place when something changes.
• Treating symptoms instead of the constraint. Flat sales get a marketing budget when the real problem is somewhere else entirely. The symptom gets attention. The disease keeps bleeding.
• Confusing a full dashboard with a diagnosis. Watching fifty metrics is not the same as knowing which one is killing the number. More data is not more clarity.
• Working every constraint at once. Spreading effort across five issues means none of them actually move. One binding constraint is doing most of the damage.
• Scoring the business with no target. A biomarker reading only means something measured against the Breakeven Sales figure. Without the number, a score is just trivia.

What Happens Without a BBI Reading

Without the Business Biomarker Index, an owner has a Breakeven Sales number and no verdict on whether the business can actually hit it. That gap gets filled with hope, and hope is not a plan. A $6 million services firm ran its numbers, saw a Breakeven Sales figure it felt confident about, and spent the next two quarters chasing new logos. Revenue rose 12 percent. Owner pay stayed flat. The real constraint had never been top-line demand, it was a margin leak that ate every new dollar before it reached the floor. Without a BBI reading, that leak stayed invisible for two full quarters while the owner celebrated a growth number that never touched what they actually took home.

Signs Your Business Needs a Biomarker Reading

A business rarely announces which constraint is binding it. It sends symptoms instead. These are the ones that most often point to a hidden constraint.

• You keep treating the same problem and it keeps coming back. A symptom that returns after every fix is usually downstream of a constraint you have not named.
• Effort goes up and the number does not move. When harder work stops producing results, the business is being held by a limit that effort cannot overcome.
• You are working five priorities at once. A business fighting on five fronts is usually losing on the one that matters, because attention is spread too thin to move it.
• Your instinct and your results disagree. When the problem you feel most is not the one the numbers point to, a diagnosis is the only way to settle it.
• You have dashboards but no verdict. Watching many metrics without knowing which one is decisive is a sign you have measurement without diagnosis.

How RTO Fits The Aldebert Ecosystem

No single diagnostic runs a business, and BBI does not stand alone. It is the last stop in a sequence, and the order is the point. Return to Owner (RTO) diagnoses the company and captures 11 proprietary Business Biomarkers. Those biomarkers feed directly into Layer Cake, which stacks from its foundation, Minimum Mandatory Profit (MMP), and resolves upward to a Breakeven Sales figure. The Business Biomarker Index is the score that follows: the composite read on whether the business can actually reach that number, and which single constraint is most likely to stop it.

Underneath MMP sits the Working Capital Gap, the cash the operating cycle silently demands before any of this math holds up. The flow is deliberate and it runs in one direction: RTO captures the biomarkers, Layer Cake stacks them into a target, and BBI tells you whether you can hit it. BBI is never the starting point. It is always the verdict.

Across more than 86,000 diagnostics, over $2 billion in profit leaks recovered, and $1 billion in consulting fees generated by the diagnostic team I built and led at ISI over 26 years, the pattern held in businesses from $1M–$100M in revenue. The owner who runs one diagnostic in isolation gets a data point. The owner who runs the full sequence gets a system, and a system is what turns a business from something an owner hopes is working into something an owner can prove is working.

Frequently Asked Questions